关注
Michael A Curran
Michael A Curran
Associate Professor, The University of Texas MD Anderson Cancer Center
在 mdanderson.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
MA Curran, W Montalvo, H Yagita, JP Allison
Proceedings of the National Academy of Sciences 107 (9), 4275-4280, 2010
20972010
PD-L1 expression in triple-negative breast cancer
EA Mittendorf, AV Philips, F Meric-Bernstam, N Qiao, Y Wu, S Harrington, ...
Cancer immunology research 2 (4), 361-370, 2014
13302014
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
SA Quezada, KS Peggs, MA Curran, JP Allison
The Journal of clinical investigation 116 (7), 1935-1945, 2006
7972006
Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype
K Gabrusiewicz, B Rodriguez, J Wei, Y Hashimoto, LM Healy, SN Maiti, ...
JCI insight 1 (2), 2016
4322016
Combining immune checkpoint blockade and tumor-specific vaccine for patients with incurable human papillomavirus 16–related cancer: a phase 2 clinical trial
E Massarelli, W William, F Johnson, M Kies, R Ferrarotto, M Guo, L Feng, ...
JAMA oncology 5 (1), 67-73, 2019
4252019
Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer
S Chouaib, MZ Noman, K Kosmatopoulos, MA Curran
Oncogene 36 (4), 439-445, 2017
3352017
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
P Jayaprakash, M Ai, A Liu, P Budhani, T Bartkowiak, J Sheng, C Ager, ...
The Journal of clinical investigation 128 (11), 5137-5149, 2018
3172018
Ipilimumab with stereotactic ablative radiation therapy: phase I results and immunologic correlates from peripheral T cells
C Tang, JW Welsh, P De Groot, E Massarelli, JY Chang, KR Hess, S Basu, ...
Clinical Cancer Research 23 (6), 1388-1396, 2017
3032017
4-1BB agonists: multi-potent potentiators of tumor immunity
T Bartkowiak, MA Curran
Frontiers in oncology 5, 117, 2015
2912015
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression
Q Hu, Y Ye, LC Chan, Y Li, K Liang, A Lin, SD Egranov, Y Zhang, W Xia, ...
Nature immunology 20 (7), 835-851, 2019
2832019
Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production
MA Curran, M Kim, W Montalvo, A Al-Shamkhani, JP Allison
PloS one 6 (4), e19499, 2011
2752011
PD-L1 expression in triple-negative breast cancer. Cancer Immunol. Res. 2014; 2: 361–370. doi: 10.1158/2326-6066
EA Mittendorf, AV Philips, F Meric-Bernstam, N Qiao, Y Wu, S Harrington, ...
CIR-13-0127.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0
241
Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin
MA Curran, TL Geiger, W Montalvo, M Kim, SL Reiner, A Al-Shamkhani, ...
Journal of Experimental Medicine 210 (4), 743-755, 2013
2052013
STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial
MJ Reilley, P McCoon, C Cook, P Lyne, R Kurzrock, Y Kim, R Woessner, ...
Journal for immunotherapy of cancer 6, 1-10, 2018
1982018
Development of immunotherapy combination strategies in cancer
TA Yap, EE Parkes, W Peng, JT Moyers, MA Curran, HA Tawbi
Cancer discovery 11 (6), 1368-1397, 2021
1752021
Intratumoral STING activation with T-cell checkpoint modulation generates systemic antitumor immunity
CR Ager, MJ Reilley, C Nicholas, T Bartkowiak, AR Jaiswal, MA Curran
Cancer immunology research 5 (8), 676-684, 2017
1622017
Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors
MA Curran, SM Kaiser, PL Achacoso, GP Nolan
Molecular Therapy 1 (1), 31-38, 2000
1592000
Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors
MA Curran, JP Allison
Cancer research 69 (19), 7747-7755, 2009
1582009
Immune biology of glioma-associated macrophages and microglia: functional and therapeutic implications
J Wei, P Chen, P Gupta, M Ott, D Zamler, C Kassab, KP Bhat, MA Curran, ...
Neuro-oncology 22 (2), 180-194, 2020
1512020
PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell–Driven Antitumor Immunity
SL Buchan, M Fallatah, SM Thirdborough, VY Taraban, A Rogel, ...
Clinical cancer research 24 (10), 2383-2394, 2018
1052018
系统目前无法执行此操作,请稍后再试。
文章 1–20